This inventor holds 4 USPTO granted patents and 5 published patent applications. Top assignees: Inovio Pharmaceuticals, Inc., University of Pennsylvania. Active years: 2018-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2018-2022
Title: The Innovative Contributions of Seleeke Flingai
Introduction
Seleeke Flingai is a notable inventor based in Minneapolis, MN, who has made significant contributions to the field of biotechnology. With a total of four patents to his name, Flingai's work focuses on the development of DNA antibody constructs and their applications in medicine. His innovative approach has the potential to revolutionize the treatment of various diseases.
Latest Patents
Flingai's latest patents include groundbreaking compositions that involve recombinant nucleic acid sequences encoding antibodies. These patents disclose methods for generating synthetic antibodies in subjects through the administration of these compositions. Furthermore, his work outlines methods for preventing and treating diseases using these innovative compositions and generation techniques.
Career Highlights
Throughout his career, Seleeke Flingai has worked with prestigious organizations such as the University of Pennsylvania and Inovio Pharmaceuticals, Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to cutting-edge research.
Collaborations
Flingai has had the opportunity to work alongside esteemed colleagues, including David B Weiner and Karuppiah Muthumani. These collaborations have further enhanced his research and development efforts in the biotechnology sector.
Conclusion
In summary, Seleeke Flingai is an accomplished inventor whose work in DNA antibody constructs holds promise for advancing medical treatments. His innovative patents and collaborations reflect his commitment to improving healthcare through scientific discovery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile